生検装置市場- 世界の産業規模、シェア、動向、機会、予測、製品タイプ別、疾患タイプ別、解剖学別、ガイダンス技術別、地域別、競合別、2020-2030年

生検装置の世界市場規模は、2024年に61億7,000万米ドルで、予測期間中のCAGRは6.18％を記録し、2030年には88億4,000万米ドルに達すると予測されています。

同市場は、がん罹患率の増加と正確な診断方法の必要性によって牽引されるヘルスケア産業の重要なセグメントです。生検装置は、分析のために組織サンプルを採取することで、病気、特にがんを早期段階で特定するのに不可欠です。需要は、技術革新、高齢化、画像誘導生検やリキッドバイオプシーのような低侵襲手技への嗜好の高まりによってさらに煽られています。ロボット工学とAIの進歩も診断精度と手技効率を高めています。

市場促進要因

がん罹患率の上昇

主な市場課題

生検手順の高コスト

主要市場動向

低侵襲技術の成長

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の生検装置市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品タイプ別（組織生検、液体生検）
  • 疾患の種類別（がん、感染症、自己免疫疾患、非がん性疾患、その他）
  • 解剖学的構造別（乳房、肺、骨、肝臓、子宮/子宮頸部/卵巣、腹部、前立腺、心臓、皮膚、その他）
  • 誘導技術別（X線誘導生検、超音波誘導生検、MRI誘導生検、CT誘導生検）
  • 地域別
  • 企業別（2024）
• 市場マップ
  • 製品タイプ別
  • 疾患タイプ別
  • 解剖学別
  • ガイダンステクニック別
  • 地域別

第5章 アジア太平洋地域の生検装置市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品タイプ別
  • 疾患タイプ別
  • 解剖学別
  • ガイダンステクニック別
  • 国別
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第6章 欧州の生検装置市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第7章 北米の生検装置市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第8章 南米の生検装置市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第9章 中東・アフリカの生検装置市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第10章 市場力学

• 促進要因
• 課題

第11章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第12章 世界の生検装置市場：SWOT分析

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Argon Medical Devices, Inc.
• B. Braun SE
• Becton, Dickinson and Company
• Boston Scientific Corporation
• Cardinal Health, Inc.
• Cook Medical Inc.
• Conmed Corporation
• FUJIFILM Holdings Corporation
• GE HealthCare
• Inrad, Inc.

第15章 戦略的提言

第16章 調査会社について・免責事項

The Global Biopsy Devices Market was valued at USD 6.17 billion in 2024 and is anticipated to reach USD 8.84 billion by 2030, registering a CAGR of 6.18% during the forecast period. This market is a vital segment of the healthcare industry, driven by the growing incidence of cancer and the need for precise diagnostic methods. Biopsy devices are essential in identifying diseases at early stages, particularly cancer, by collecting tissue samples for analysis. The demand is further fueled by technological innovations, an aging population, and the increasing preference for minimally invasive procedures like image-guided and liquid biopsies. Advancements in robotics and AI are also enhancing diagnostic accuracy and procedural efficiency.

Key Market Drivers

Rising Cancer Prevalence

The escalating global incidence of cancer significantly propels the demand for biopsy devices. As cancer becomes more widespread, the need for accurate diagnostic methods grows more urgent. Biopsy procedures are critical in confirming cancer diagnoses, determining types and stages, and guiding effective treatment plans. According to the Union for International Cancer Control (UICC), the number of new cancer cases is projected to exceed 35 million by 2050, marking a 77% increase from 2022. This alarming rise underscores the importance of biopsy tools in healthcare systems, as early and reliable diagnosis is central to improving patient outcomes and expanding access to appropriate therapies.

Key Market Challenges

High Cost of Biopsy Procedures

A significant challenge for the global biopsy devices market is the high cost associated with biopsy procedures. These costs include not only the price of specialized equipment but also expenses related to diagnostics, professional services, and post-procedure care. For patients, especially those with limited financial means or inadequate insurance coverage, out-of-pocket expenses can deter timely diagnosis. Even for healthcare providers, the acquisition and maintenance of advanced biopsy equipment, workforce training, and regulatory compliance impose substantial financial burdens. These economic constraints limit accessibility and slow adoption, particularly in developing regions, posing a barrier to market expansion.

Key Market Trends

Growth of Minimally Invasive Techniques

The increasing adoption of minimally invasive biopsy techniques is a transformative trend in the global biopsy devices market. Unlike traditional surgical biopsies, these methods-such as fine-needle aspiration, core needle biopsies, and image-guided procedures-offer less invasive alternatives with reduced discomfort and faster recovery. These patient-friendly approaches not only improve diagnostic efficiency but also increase the appeal of biopsy procedures, driving demand. Minimally invasive methods enable sampling from hard-to-reach areas and are associated with lower complication rates. Their growing acceptance among both patients and providers is accelerating market growth and reshaping diagnostic practices across healthcare systems.

Key Market Players

• Argon Medical Devices, Inc.
• B. Braun SE
• Becton, Dickinson and Company
• Boston Scientific Corporation
• Cardinal Health, Inc.
• Cook Medical Inc.
• Conmed Corporation
• FUJIFILM Holdings Corporation
• GE HealthCare
• Inrad, Inc

Report Scope:

In this report, the Global Biopsy Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biopsy Devices Market, By Product Type:

• Tissue Biopsy
• Liquid Biopsy

Biopsy Devices Market, By Disease Type:

• Cancer
• Infections
• Autoimmune Disorders
• Non-Cancerous Indications
• Others

Biopsy Devices Market, By Anatomy:

• Breast
• Lung
• Bone
• Liver
• Uterus/Cervix/Ovary
• Abdomen
• Prostate
• Cardiac
• Skin
• Others

Biopsy Devices Market, By Guidance Technique:

• X-Ray-Guided Biopsy
• Ultrasound-Guided Biopsy
• MRI-Guided Biopsy
• CT-Guided Biopsy

Biopsy Devices Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Biopsy Devices Market.

Available Customizations:

Global Biopsy Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Biopsy Devices Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Product Type (Tissue Biopsy, Liquid Biopsy)
  • 4.2.2. By Disease Type (Cancer, Infections, Autoimmune Disorders, Non-Cancerous Indications, Others)
  • 4.2.3. By Anatomy (Breast, Lung, Bone, Liver, Uterus/Cervix/Ovary, Abdomen, Prostate, Cardiac, Skin, Others)
  • 4.2.4. By Guidance Technique (X-Ray-Guided Biopsy, Ultrasound-Guided Biopsy, MRI-Guided Biopsy, CT-Guided Biopsy)
  • 4.2.5. By Region
  • 4.2.6. By Company (2024)
• 4.3. Market Map
  • 4.3.1. By Product Type
  • 4.3.2. By Disease Type
  • 4.3.3. By Anatomy
  • 4.3.4. By Guidance Technique
  • 4.3.5. By Region

5. Asia Pacific Biopsy Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type
  • 5.2.2. By Disease Type
  • 5.2.3. By Anatomy
  • 5.2.4. By Guidance Technique
  • 5.2.5. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Biopsy Devices Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Product Type
      • 5.3.1.2.2. By Disease Type
      • 5.3.1.2.3. By Anatomy
      • 5.3.1.2.4. By Guidance Technique
  • 5.3.2. India Biopsy Devices Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Product Type
      • 5.3.2.2.2. By Disease Type
      • 5.3.2.2.3. By Anatomy
      • 5.3.2.2.4. By Guidance Technique
  • 5.3.3. Australia Biopsy Devices Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Product Type
      • 5.3.3.2.2. By Disease Type
      • 5.3.3.2.3. By Anatomy
      • 5.3.3.2.4. By Guidance Technique
  • 5.3.4. Japan Biopsy Devices Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Product Type
      • 5.3.4.2.2. By Disease Type
      • 5.3.4.2.3. By Anatomy
      • 5.3.4.2.4. By Guidance Technique
  • 5.3.5. South Korea Biopsy Devices Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Product Type
      • 5.3.5.2.2. By Disease Type
      • 5.3.5.2.3. By Anatomy
      • 5.3.5.2.4. By Guidance Technique

6. Europe Biopsy Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Disease Type
  • 6.2.3. By Anatomy
  • 6.2.4. By Guidance Technique
  • 6.2.5. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Biopsy Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Disease Type
      • 6.3.1.2.3. By Anatomy
      • 6.3.1.2.4. By Guidance Technique
  • 6.3.2. Germany Biopsy Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Disease Type
      • 6.3.2.2.3. By Anatomy
      • 6.3.2.2.4. By Guidance Technique
  • 6.3.3. Spain Biopsy Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Disease Type
      • 6.3.3.2.3. By Anatomy
      • 6.3.3.2.4. By Guidance Technique
  • 6.3.4. Italy Biopsy Devices Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Product Type
      • 6.3.4.2.2. By Disease Type
      • 6.3.4.2.3. By Anatomy
      • 6.3.4.2.4. By Guidance Technique
  • 6.3.5. United Kingdom Biopsy Devices Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Product Type
      • 6.3.5.2.2. By Disease Type
      • 6.3.5.2.3. By Anatomy
      • 6.3.5.2.4. By Guidance Technique

7. North America Biopsy Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Disease Type
  • 7.2.3. By Guidance Technique
  • 7.2.4. By Anatomy
  • 7.2.5. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Biopsy Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Disease Type
      • 7.3.1.2.3. By Anatomy
      • 7.3.1.2.4. By Guidance Technique
  • 7.3.2. Mexico Biopsy Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Disease Type
      • 7.3.2.2.3. By Anatomy
      • 7.3.2.2.4. By Guidance Technique
  • 7.3.3. Canada Biopsy Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Disease Type
      • 7.3.3.2.3. By Anatomy
      • 7.3.3.2.4. By Guidance Technique

8. South America Biopsy Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Disease Type
  • 8.2.3. By Guidance Technique
  • 8.2.4. By Anatomy
  • 8.2.5. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Biopsy Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Disease Type
      • 8.3.1.2.3. By Anatomy
      • 8.3.1.2.4. By Guidance Technique
  • 8.3.2. Argentina Biopsy Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Disease Type
      • 8.3.2.2.3. By Anatomy
      • 8.3.2.2.4. By Guidance Technique
  • 8.3.3. Colombia Biopsy Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Disease Type
      • 8.3.3.2.3. By Anatomy
      • 8.3.3.2.4. By Guidance Technique

9. Middle East and Africa Biopsy Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Disease Type
  • 9.2.3. By Anatomy
  • 9.2.4. By Guidance Technique
  • 9.2.5. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Biopsy Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Disease Type
      • 9.3.1.2.3. By Anatomy
      • 9.3.1.2.4. By Guidance Technique
  • 9.3.2. Saudi Arabia Biopsy Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Disease Type
      • 9.3.2.2.3. By Anatomy
      • 9.3.2.2.4. By Guidance Technique
  • 9.3.3. UAE Biopsy Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Disease Type
      • 9.3.3.2.3. By Anatomy
      • 9.3.3.2.4. By Guidance Technique

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Biopsy Devices Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. Argon Medical Devices, Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (In case of listed)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. B. Braun SE
• 14.3. Becton, Dickinson and Company
• 14.4. Boston Scientific Corporation
• 14.5. Cardinal Health, Inc.
• 14.6. Cook Medical Inc.
• 14.7. Conmed Corporation
• 14.8. FUJIFILM Holdings Corporation
• 14.9. GE HealthCare
• 14.10. Inrad, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer